DEVELOPMENT AND EVALUATION OF NATURAL GUM-BASED SUSTAINED-RELEASE TABLETS FOR LEVOSULPIRIDE AND ALPRAZOLAM
Abstract
Natural plant-derived gums, being renewable and biocompatible, present promising applications in pharmaceutical formulations. In this study, hydrophilic gums extracted from Velama, Rekka, and Mardi plants were characterized for their potential in sustained-release tablet formulations. The extracted gums demonstrated sufficient yield and favorable physicochemical properties, including low moisture content and near-neutral pH, indicating suitability for moisture-sensitive drugs and reduced irritation. Micromeritic analyses confirmed satisfactory flow properties, and Preformulation and post-compression evaluations revealed excellent compatibility, mechanical strength, and stability under accelerated conditions. In vitro and in vivo studies demonstrated controlled drug release profiles, with Velama and Mardi gums showing superior matrix-forming capabilities compared to Rekka gum. This study highlights the efficacy of natural polymers in enhancing drug release efficiency, dosing accuracy, and patient compliance in pharmaceutical applications.
References
2. Bonferoni MC, Rossi S, Ferrari F, Stavik E, Pena-Romero A, Caramella C. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech. 2000; 1 (2):15.
3. Mulhbacher J, Alexandru MM. Cross linked high amylase starch derivatives for drug release III: Diffusion properties. Jnt J Pharm. 2005; 297(1-2): 22-29.
4. Herman J, Remon JP, De, Vilder J. Modified starches as hydrophilic matrices for controlled oral delivery J. Production and characterisation of thermally modified starches Int J Pharm. 1989; 56 (1): 51-63.
5. Herman J, Remon JP. Modified starches as hydrophilic matrices for controlled oral delivery. II. In vitro drug release evaluation of thermally modified starches. Int J Pharm. 1989; 56 (1): 65-70.
6. Herman J, Remon JP. Modified starches as hydrophilic matrices for controlled oral delivery III. Evaluation of sustained-release theophylline formulations based on thermal modified starch matrices in dogs. Int J Pharm. 1990; 63(3): 201-205.
7. Visavarungroj N, Herman J, Remon JP. Crosslinked starch as sustained release agent. Drug Dev Ind Pharm. 1990; 16 (7): 1091-1108.
8. Kolen JJ, McGinity JW, Wilber WR, Raymond CR, Paul JS, Paul JW. Handbook of Phannaceutical Excipients. The Pharmaceutical Press and The American Pharmaceutical Association, (2003) 89-92.
9. Patel M, Patel R Patel R, Patel JK, Bharadia PD. Patel MM. Carbopol: A versatile polymer. Drug Delivery Tech. 2006: 6(3): 32.
10. Bulut-oner F, Capan Y, Kas S, Oner L, Hincal AA. Sustained release isoniazid tablets I- formulation and in vitro evaluation. Farmaco. 1989; 44(7-8): 739-752.
11. Gohel MC, Parikh RK, Padshala MN, Sarvaiya KG, Jena DG. Formulation and optimization of directly compressible isoniazid modified release matrix tablet. Indian J Pharm Sci. 2007; 69(5): 640-645.
12. Baveja SK, Ranga Rao KV, Singh A. Gombar VK. Release characteristics of some bronchodilators from compressed hydrophilic polymeric matrices and their correlation with molecular geometry. 1nt J Pharm. 1988; 41 (1-2): 55-62.
13. Velasco M, Ford JL Rowe P, Rajabi-Siahboomi AR. Influence of drug: hydroxypropylmethylcellulose ratio, drug and polymer particle size and compression force on the release of diclofenac sodium from HPMC tablet. J Controlled Release. 1999: 57(1): 75-85.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.